Quantcast
Last updated on April 18, 2014 at 12:32 EDT

Latest Sigma-Aldrich Stories

2013-07-23 08:32:30

ST. LOUIS, July 23, 2013 /PRNewswire/ -- HIGHLIGHTS: Q2 2013 Results (all percentages are to comparable periods in 2012) Q2 2013 reported sales increased 3% to $681 million. Organic sales growth was 4%. Organic sales growth by business unit was 3% for Research, 6% for Applied and 2% for SAFC Commercial. Changes in foreign currency exchange rates reduced otherwise reportable overall sales by 1%. Q2 2013 reported diluted EPS was $0.98 compared to Q2 2012 reported diluted EPS...

2013-07-23 08:23:30

ST. LOUIS, July 23, 2013 /PRNewswire/ -- HIGHLIGHTS: Q2 2013 Results (all percentages are to comparable periods in 2012) Q2 2013 reported sales increased 3% to $681 million. Organic sales growth was 4%. Organic sales growth by business unit was 3% for Research, 6% for Applied and 2% for SAFC Commercial. Changes in foreign currency exchange rates reduced otherwise reportable overall sales by 1%. Q2 2013 reported diluted EPS was $0.98 compared to Q2 2012 reported diluted EPS...

2013-07-18 08:29:01

Agreement marks first partnership of its kind between a research institution and reagents company; third major deal in TSRI's new partnering strategy SAINT LOUIS and LA JOLLA, Calif., July 18, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced a partnership with The Scripps Research Institute (TSRI) to fund research and provide immediate, day-of-publication access to TSRI researchers' discoveries for the synthesis and analysis of potential drugs. The...

2013-07-16 23:19:37

New England Peptide, Inc. (NEP) and Cambridge Isotope Laboratories, Inc. (CIL) announced a joint manufacturing and marketing agreement of pre-loaded resins for the synthesis of peptide stable isotope standards (SIS) for quantitative proteomics. Gardner, MA (PRWEB) July 16, 2013 New England Peptide, Inc. (NEP) and Cambridge Isotope Laboratories, Inc. (CIL) announced a joint manufacturing and marketing agreement of pre-loaded resins for the synthesis of peptide stable isotope standards...

2013-07-16 16:25:47

RICHMOND, Calif., July 16, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will release its second quarter 2013 financial results on Wednesday, July 24, 2013, after the market closes. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the company will review the financial results and discuss other business matters. (Logo:...

2013-07-09 12:22:22

ST. LOUIS, July 9, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) will hold its quarterly conference call to discuss second quarter 2013 financial results on Tuesday, July 23, 2013, at 11:00 AM EDT. Conference call details:Date: July 23, 2013 Time: 11:00 AM EDT Conference ID#: 45732738 Listen and view the presentation slides via the Internet at http://investor.sigmaaldrich.com/ or call one of the following numbers for audio only:Domestic: (877)...

2013-07-02 16:23:43

RICHMOND, Calif., July 2, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Philip Gregory, D.Phil., Sangamo's vice president of research and CSO, will provide an update on the progress of Sangamo's ZFP Therapeutic(® )development programs and an overview of the company's business strategy at 1:30 pm ET on Wednesday, July 10, 2013, at the 8th Annual JMP Securities Healthcare Conference which will be held in New York City. (Logo:...

2013-06-28 12:24:07

DUBLIN, June 28, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/42wzs7/global) has announced the addition of the "Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 - 2017)" [http://www.researchandmarkets.com/research/42wzs7/global ] report to their offering. (Logo:...

2013-06-26 08:32:12

RADNOR, Pa., June 26, 2013 /PRNewswire/ -- VWR International, LLC, a global solutions provider of laboratory supplies, equipment and services, announced today that Peter Schuele has joined VWR as the Company's Senior Vice President and President of European Lab Business. (Logo: http://photos.prnewswire.com/prnh/20101109/NY97837LOGO) Mr. Schuele joins VWR from Sigma Aldrich Corporation where he served as Vice President, Supply Chain Europe, Middle East and Africa, developing and...

2013-06-25 23:31:07

AMRESCO expands capabilities to meet growing demands of its customers and the LIfe Science market. Cleveland, Ohio (PRWEB) June 25, 2013 AMRESCO, LLC, a VWR company and a Life Science leader in the supply and contract manufacturing of high purity biochemicals, reagents and research products, announced that it has invested in a new powder manufacturing facility to support growing global business to Diagnostic, Molecular Biology and Biopharmaceutical companies. AMRESCO’s investment is...